Your browser is no longer supported. Please, upgrade your browser.
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E25.17 EPS (ttm)6.69 Insider Own0.07% Shs Outstand2.63B Perf Week1.08%
Market Cap444.30B Forward P/E16.24 EPS next Y10.37 Insider Trans-0.26% Shs Float2.63B Perf Month-0.76%
Income17.88B PEG3.07 EPS next Q2.12 Inst Own70.00% Short Float0.58% Perf Quarter1.59%
Sales91.45B P/S4.86 EPS this Y-4.20% Inst Trans0.05% Short Ratio1.96 Perf Half Y-2.21%
Book/sh26.69 P/B6.31 EPS next Y5.84% ROA10.20% Target Price186.44 Perf Year0.30%
Cash/sh11.75 P/C14.33 EPS next 5Y8.19% ROE26.60% 52W Range151.47 - 179.92 Perf YTD-1.57%
Dividend4.24 P/FCF38.43 EPS past 5Y-0.30% ROI14.60% 52W High-5.05% Beta0.73
Dividend %2.52% Quick Ratio1.10 Sales past 5Y3.30% Gross Margin67.50% 52W Low12.79% ATR2.95
Employees134500 Current Ratio1.30 Sales Q/Q10.70% Oper. Margin21.40% RSI (14)57.26 Volatility2.74% 1.52%
OptionableYes Debt/Eq0.48 EPS Q/Q3.00% Profit Margin19.60% Rel Volume0.99 Prev Close168.38
ShortableYes LT Debt/Eq0.43 EarningsJan 25 BMO Payout61.30% Avg Volume7.82M Price170.84
Recom2.10 SMA200.82% SMA502.69% SMA2002.29% Volume576,150 Change1.46%
Dec-17-21Initiated Goldman Neutral $161
Dec-15-21Reiterated Citigroup Buy $192 → $195
Sep-07-21Downgrade Morgan Stanley Overweight → Equal-Weight $187
May-28-21Resumed Morgan Stanley Overweight $187
Apr-28-20Downgrade UBS Buy → Neutral $163 → $160
Apr-22-20Upgrade BofA/Merrill Neutral → Buy $150 → $175
Mar-05-20Initiated Citigroup Buy $163
Dec-19-19Upgrade Barclays Equal Weight → Overweight $173
Dec-17-19Upgrade Morgan Stanley Equal-Weight → Overweight $145 → $170
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-27-22 09:38AM  
06:22AM  
06:00AM  
06:00AM  
05:51AM  
Jan-26-22 09:38PM  
06:01PM  
05:38PM  
05:38PM  
05:38PM  
05:33PM  
02:49PM  
01:39PM  
01:38PM  
10:02AM  
09:48AM  
09:38AM  
07:52AM  
07:31AM  
Jan-25-22 05:38PM  
04:56PM  
04:43PM  
04:28PM  
04:22PM  
04:08PM  
04:07PM  
03:29PM  
03:15PM  
02:39PM  
01:02PM  
01:01PM  
12:01PM  
11:31AM  
11:28AM  
11:20AM  
11:04AM  
10:52AM  
10:31AM  
10:31AM  
09:04AM  
08:34AM  
07:55AM  
07:14AM  
06:45AM  
06:37AM  
06:29AM  
06:25AM  
01:41AM  
Jan-24-22 09:38PM  
05:38PM  
03:27PM  
01:38PM  
01:38PM  
01:38PM  
10:44AM  
10:01AM  
09:56AM  
08:58AM  
04:24AM  
Jan-23-22 05:52AM  
Jan-22-22 08:45PM  
Jan-21-22 09:38PM  
03:47PM  
03:33PM  
01:59PM  
01:47PM  
10:30AM  
09:38AM  
09:18AM  
Jan-20-22 09:38PM  
09:38PM  
05:38PM  
05:38PM  
04:59PM  
04:58PM  
03:43PM  
01:38PM  
01:20PM  
11:55AM  
10:45AM  
Jan-19-22 05:45PM  
04:03PM  
03:48PM  
01:51PM  
01:09PM  
12:25PM  
10:37AM  
10:00AM  
09:38AM  
09:38AM  
09:38AM  
09:38AM  
08:00AM  
Jan-18-22 05:38PM  
03:46PM  
03:19PM  
01:48PM  
01:38PM  
01:38PM  
11:01AM  
Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Duato JoaquinCEOJan 14Option Exercise65.3784,4235,518,732280,475Jan 19 08:54 PM
Gorsky AlexDirectorJan 14Option Exercise65.37231,95115,162,637695,601Jan 19 08:54 PM
Decker Robert JController, CAODec 07Option Exercise72.545,000362,70019,215Dec 09 04:43 PM
Decker Robert JController, CAODec 07Sale163.215,000816,05014,215Dec 09 04:43 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 12Option Exercise0.0035,0620289,864Feb 17 07:09 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 12Option Exercise0.0013,6060121,191Feb 17 07:09 PM
Ullmann Michael HExec VP, General CounselFeb 12Option Exercise0.0014,4440157,728Feb 17 07:09 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 12Option Exercise0.0010,362068,837Feb 17 07:09 PM
Wolk Joseph JExec VP, CFOFeb 12Option Exercise0.005,086024,513Feb 17 07:09 PM
Decker Robert JController, CAOFeb 12Option Exercise0.001,310014,701Feb 17 07:09 PM
Gorsky AlexChairman, CEOFeb 12Option Exercise0.0075,1050507,925Feb 17 07:09 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 12Option Exercise0.007,145042,960Feb 17 07:09 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 12Option Exercise0.0033,0210209,490Feb 17 07:09 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 12Option Exercise0.0012,8730113,039Feb 17 07:09 PM
Sneed Michael EEVP, Global Corp Aff & CCOFeb 12Option Exercise0.009,211065,290Feb 17 07:09 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 12Option Exercise0.0013,136034,834Feb 17 07:09 PM